Activation of CD4 + lymphocytes with a memory phenotype enables immune cells to mount a memory response to tumor antigens, thereby preventing tumor recurrence in patients with different cancers, which is predictive of longer survival [33]. This evidence concerns the gene CD4 and cancer.